Validity and Cost-Effectiveness of a New Screening Test for Hepatocellular Carcinoma
N/A
40 Years
70 Years
40 Years
70 Years
Not Enrolling
Both
Hepatitis B Virus
Both
Hepatitis B Virus
Trial Information
Validity and Cost-Effectiveness of a New Screening Test for Hepatocellular Carcinoma
Inclusion Criteria:
- Age between 40 and 70 years
- Seropositive for HBsAg
- Child's A or B
- Life expectancy of more than 2 years
Exclusion Criteria:
- Non-HBV related cirrhosis
- History of malignancy
Type of Study:
Observational
Study Design:
Time Perspective: Prospective
Authority:
Hong Kong: Joint CUHK-NTEC Clinical Research Ethics Committee
Study ID:
RHCC002
NCT ID:
NCT00912847
Start Date:
October 1997
Completion Date:
April 2004
Related Keywords:
- Hepatitis B Virus
- HBV carriers
- Carcinoma
- Hepatitis
- Hepatitis A
- Hepatitis B
- Carcinoma, Hepatocellular
Name | Location |
|---|
